ERIN ROBERTSON: Open Payments
NPI 1639641202 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 20 payments from 10 companies in 2025. Trend: 2023 $480 · 2024 $659 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $89 |
| Amgen Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $51 |
| PFIZER INC. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $28 |
| Dexcom, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: OTEZLA, Wegovy, NURTEC ODT, MOUNJARO, CAPLYTA, JARDIANCE, Dexcom G6 Transmitter, AIRSUPRA.
Industry payments across OK — which companies pay providers there.
